AMENDED AND RESTATED STRATEGIC MASTER SERVICES AGREEMENTStrategic Master Services Agreement • November 19th, 2004 • Duska Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledNovember 19th, 2004 Company Industry JurisdictionTHIS AMENDED AND RESTATED STRATEGIC MASTER SERVICES AGREEMENT (“Agreement”) is effective as of 10th day of February, 2004, by and between CATO RESEARCH LTD., a North Carolina corporation (“CRL”), and the undersigned client, DUSKA SCIENTIFIC CO., a Pennsylvania corporation (“CLIENT”).
STRATEGIC MASTER SERVICES AGREEMENTStrategic Master Services Agreement • March 31st, 2009 • Cordex Pharma, Inc. • Biological products, (no disgnostic substances) • North Carolina
Contract Type FiledMarch 31st, 2009 Company Industry JurisdictionThis Strategic Master Services Agreement (this “Agreement”) is made as of January 22, 2009 (the “Effective Date”) by and between Cato Holding Company d/b/a Cato BioVentures, a North Carolina corporation (“CBV”), and Cordex Pharma, Inc., a Nevada corporation (“Cordex”). Each of CBV and Cordex may be referred to herein separately as a “Party” and collectively as the “Parties.” As used in this Agreement, “Affiliates” means any corporation, firm, partnership, or other entity which is controlled by or is under common control with a Party. For the purpose of this definition, “control” shall mean the power to direct, or cause the direction of, the management and policies of an entity through the ownership of at least fifty percent (50%) of the voting share capital of such entity or any other comparable equity, by contract, or by ownership interest.
STRATEGIC MASTER SERVICES AGREEMENTStrategic Master Services Agreement • September 20th, 2007 • Sontra Medical Corp • Electromedical & electrotherapeutic apparatus • Delaware
Contract Type FiledSeptember 20th, 2007 Company Industry JurisdictionTHIS STRATEGIC MASTER SERVICES AGREEMENT (the “Agreement”) is made as of September 14, 2007 (the “Effective Date”) by and between Cato Research Ltd., a North Carolina corporation (“CATO RESEARCH”), and Sontra Medical Corporation, a Minnesota corporation (“CLIENT”). Each of CATO RESEARCH and CLIENT may be referred to herein separately as a “Party” and collectively as the “Parties.” As used in this Agreement, “Affiliates” means any corporation, firm, partnership, or other entity which is controlled by or is under common control with a Party. For the purpose of this definition, “control” shall mean the power to direct, or cause the direction of, the management and policies of an entity through the ownership of at least fifty percent (50%) of the voting share capital of such entity or any other comparable equity, by contract, or by ownership interest.